Teradyne (TER) Form 4: CEO sold 554 shares under 10b5-1 plan
Rhea-AI Filing Summary
Insider transaction report: Teradyne, Inc. director and President & CEO Gregory Stephen Smith reported a sale of 554 shares of Teradyne common stock on 09/22/2025 at a price of $126.39 per share. The filing states the shares were sold pursuant to a 10b5-1 trading plan adopted by the reporting person on February 4, 2025. After the reported sale, the Form 4 lists 95,884.995 shares beneficially owned by the reporting person. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/24/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine, pre-planned insider sale under a 10b5-1 plan; not a standalone signal of material company change.
The transaction is a small, disclosed sale executed under a documented 10b5-1 plan adopted on February 4, 2025, which reduces the risk that the sale was based on non-public information. The reported sale amount—554 shares at $126.39—represents a de minimis change relative to the reported post-transaction beneficial ownership of 95,884.995 shares. The use of an attorney-in-fact signature is common for timely filings. From a governance perspective, this filing reflects compliance with Section 16 reporting requirements and established insider trading procedures.
TL;DR: Transaction is administratively notable but immaterial to Teradyne's valuation or capital structure.
The sale of 554 shares at $126.39 yields gross proceeds of approximately $69,996, but the Form 4 states this was executed under a pre-existing 10b5-1 plan, which typically staggers sales for personal liquidity rather than signaling company performance. The filing shows 95,884.995 shares remaining beneficially owned, suggesting continued significant insider ownership. There is no indication of additional derivative transactions or material changes to ownership percentages in this filing.